EBITDA: Income before interest, taxes, depreciation and amortization.
Vycor Medical, Inc. (VYCO) had EBITDA of $0.02M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.42M |
|
$-0.02M |
|
$0.07M |
|
$0.34M |
|
$0.41M |
|
$0.01M |
|
$-0.03M |
|
$-0.02M |
|
$-0.02M |
|
$-0.02M |
|
$-0.02M |
|
$-0.02M |
|
$-0.02M |
|
$0.01M |
|
|
EBITDA |
$0.02M |
33.37M |
|
33.37M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.64M |
|
$0.10M |
|
$0.18M |
|
$0.81M |
|
$4.93M |
|
$0.13M |
|
$0.13M |
|
$5.06M |
|
$-4.25M |
|
$-4.25M |
|
$-4.25M |
|
33.37M |
|
| Cash Flow Statement Financials | |
$0.09M |
|
$0.00M |
|
$-0.03M |
|
$0.09M |
|
$0.16M |
|
$0.07M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.13 |
|
-- |
|
-- |
|
-0.03 |
|
-0.22 |
|
82.35% |
|
1.64% |
|
1.64% |
|
-- |
|
-4.57% |
|
-5.33% |
|
$0.10M |
|
-- |
|
-- |
|
-- |
|
0.51 |
|
0.39 |
|
2.07 |
|
43.56 |
|
0.45% |
|
0.45% |
|
-2.35% |
|
0.46% |
|
$-0.13 |
|
$0.00 |
|
$0.00 |
|